Posters on the Podium

SESSION 3: Posters on the Podium

Monday • May 11, 2026 • 3:30–5:00 PM • Trailblazer’s Ballroom
Moderators: Daniela Traini, Ph.D. and Elizabeth Bielski, Ph.D.

Replacing Sugar Excipient with Polymyxins to Improve Dosing of a Dry Powder Teixobactin-Lipopeptide Hybrid for the Treatment of Pulmonary Infections
Sara Maloney Norcross
RTI International
Medium Chain Length Polyhydroxyalkanoate Nanoparticles for Controlled Drug Delivery to the Lung
Edward Attenborough
Monash University
Pulmonary Delivery of Ginkgetin Attenuates Lung Fibrosis in a Rat Model
Cimone Richardson
Virginia Commonwealth University
Use of a Modified Next Generation Impactor and Franz Cell for Characterization of the In Vitro Dissolution Performances of Innovator and Generic Dry Powder Inhalers
Zhengqi Xu and Dipesh Khanal
University of Sydney
Particle Level Assessment of Size and Composition as a Function of Aerosol Particle Size Using Optical Photothermal Infrared Microscopy: Comparison of Fluticasone/Salmeterol/Lactose in Advair Diskus and Wixela Inhub
Teri Ross
The University of Alabama at Birmingham
In Silico Evaluation of Nasal Spray Plume Angle and Ovality: Effect on Regional Nasal Deposition
Navid Monshi Tousi and Jan De Backer
FLUIDDA
Rapid Stability Modeling as a Predictor for Long-Term Standard Stability Testing of Dry Powder Inhalers
Anna Catton
University of Bristol
Predicting Pulmonary Drug Deposition Using Real-Time Connected Inhalation Data
Carolina Dantas and Ulf Krueger
PULMOTREE

Discover More

Improvement in Inhalation Technique During a Pharmacy-Led Connected Inhaler Service Evaluation in Adults with Asthma or Chronic Obstructive Pulmonary Disease
Marco Franza
Amcor
Human Factor Studies and Actuation Force in Multidose Nasal Pumps 
Goncalo Farias
Aptar Pharma
Evaluation of Regional Deposition in 3D Printed Infant Nasal Cast Models for Vaccination via Intranasal Delivery
Goncalo Farias
Aptar Pharma
A Spray-Drying Framework for Intranasal Powders Across Multiple Sites and Dryer Scales
Sana Hosseini
Aptar Pharma Services
From Droplets to Particles: Excipients Shaping Spray‑Dried Intranasal Powders
Sana Hosseini
Aptar Pharma Services
Decarbonizing the Pressurized Metered Dose Inhaler Valve: Designing a Low-Carbon Valve for the Next Generation of Pressurized Metered Dose Inhalers
Shaun Williams
Bespak
Simulating In Vitro Aerosolization Performance: A Tool to Support Valve Selection for Suspension Pressurized Metered Dose Inhaler Products
Benjamin Thorne
Bespak
Powder Rheology for Batch Comparison During Manufacturing
Ken Lo
Capsugel - Lonza
Seventy Years of Metered Dose Inhalers
Stephen Stein
CGT Pharma Consulting
A Simple Calculation to Provide Insight into Impact of Propellant on Spray Pattern
Stephen Stein
CGT Pharma Consulting
Evaluation of Permeation Enhancers for Intranasal Delivery of Epinephrine and Naloxone Hydrochloride Using a 3D Nasal Tissue Model
Veronica Freitas Blanco
Croda
Development and Characterization of Inhalable Microparticles Co-Delivering Nintedanib and Metformin for Idiopathic Pulmonary Fibrosis
Tingting Shi and Yuqing Ye
Eastern Institute of Technology
Using Rapid Deposition Analysis and Realistic Aerodynamic Particle Size Distribution Variability to Support In Silico Bioequivalence Assessment
Hosein Sadafi and Jan De Backer
FLUIDDA
Leachables Toxicological Risk Assessment: Read-Across Case Study of Permissible Daily Exposure Limit Derivation for Butyl Oligomer (C21H40)
Isaac Mohar
Gradient
Screening of Capsule-Filling Process Parameters in the Development of Spray-Dried Powder Products for Pulmonary Delivery
Marian Asch and Rui Alberto Teixeira Cruz
Harro Höfliger
In Vitro Performance of a Mannitol-Based Spray-Dried Powder Combined with Quattrii Carrier Free Dry Powder Inhaler
Irene Rossi
Harro Höfliger Verpackungsmaschinen
In Vitro Performance Assessment of Fluticasone Propionate/Salmeterol Xinafoate Blends Developed for a Capsule-Based Device
Irene Rossi
Harro Höfliger Verpackungsmaschinen
Evaluation of Albuterol Sulfate Formulations with Low Global Warming Propellants using a Non-PFAS-Coated MDI Can
Loy Britto
Healthy Airways
Critical Quality Attribute-Driven Calu-3 Air-Liquid Interface Model for Comparative Permeability Screening of Dry Powder and Liquid Formulations  
Beatriz Gamelas and Dina Morais
Hovione
Evaluation of β-lactoglobulin (Dispersome®) as a Novel Excipient for Pulmonary and Nasal Delivery
Claudia Costa
Hovione
Advancing Nasal Powder Delivery: A Structured Evolution of Device Performance
Angelo Araujo and Claudia Costa
Hovione
Determining Material Composition of Fines-Only Formulations Through X-Ray Computed Tomography
Parmesh Gajjar and Darragh Murnane
InformiX Pharma
Stability and Aerosol Characterization of ACE-2 Decoy Antibody Delivered by a Vibrating Mesh Nebulizer
Ellen Farmer
Inhalon Biopharma
Preliminary Spray Drying Screening Study for the Reformulation of Ganaxolone from Oral to Nasal Delivery
Anna Vivani and Irene Rossi
INTO
The Case for Inhaled, Thermostable Powder Vaccines Against Respiratory Pathogens in Pandemic Readiness
Svetlana Lyapustina and Beatriz Noriega Fernandes
IPAC-RS
Managing Supply Continuity During the Pressurized Metered Dose Inhaler Transition to Next Generation Propellants
Svetlana Lyapustina and Sheryl Johnson
IPAC-RS
Single Jet Impaction as an Alternative Mechanism for Soft Mist Generation
Moritz Fleischhauer
Johannes Gutenberg-Universität Mainz
A Programmable Aerosol Delivery Platform with Multi-Formulation Capability and High Aerosolization Rates
Donovan Yeates
KAER Biotherapeutics
Design of Spray-Dried Glucagon-Like Peptide-1 Exenatide Microparticles for Pulmonary Delivery: A Room-Temperature Stable Formulation of an Oxidation Sensitive Peptide
Keith Ung
Kindeva
Recording and Analysis of Healthy Subjects Breathing Maneuvers with an AdheResp Breath-Actuated Nebulizer
Keith Ung
Kindeva
Tuning Nasal Spray Performance by Formulation Design
Rob McCorkle
Kindeva
Assessment of Dissolution Profiles for Mometasone Furoate Inhalers Using a Paddle-Over-Disk Dissolution Apparatus
Katherine Polzin
Kindeva
Excipient Effects on Spray-Dried Antibody Stability: A Comparative Study
Adam Schneiderhan and Beatriz Fernandes
Lonza
Ondansetron Inhalation Powder: Bioavailability and Safety Results from Phase 1 Clinical Study
Xiaodong Li
Luxena Pharmaceuticals
Morphological Characterization of Dry Powder Inhaler Formulations: A Reaction to the US Food and Drug Administration Guidelines
Vaishnavi Kapileshwari and Mridul Majumder
M2M Pharmaceuticals
Predicting Nasal Deposition from Minimal In Vitro Data with Machine Learning
Ben Miles and Lucas Silva
Nanopharm, an Aptar Pharma Company
CC
Inhalation and Systemic Delivery of mRNA to the Lung Using a Stable Lipid Nanoparticle Platform
Cima Cina and Wendy Knowlton
Nitto BioPharma
Thermostable Powder-Based Nasal Vaccine: Preclinical Evaluation of Immunogenicity and Stability
Jonas Sävmarker
Orexo AB
Defining a Reproducible Reference Condition for 'Immediate' Actuation in Low-Global Warming Potential HFA-152a Albuterol Sulphate Suspension Pressurized Metered Dose Inhalers
David Lewis
Oz-UK Limited
Development of a Connectivity Module for an Open-Inhale-Close Device That is Both Patient-Centric and Non-Intrusive to Dry Powder Delivery
Murat Ali
Phillips Medisize
Actuation and Viscosity Dependent Aerosol Generation in Nasal Sprays: A Mechanistic Comparison of Swirl Nozzle and Soft Mist Technologies
Nicolas Buchmann
Resyca
Optimization of Spray-Dried Spectinamide Lee1810 Inhalation Powders
Erik Pena and Sara Maloney Norcross
RTI International
Budesonide Solution Formulations in HFO-1234ze(E): Novel Alternatives to Suspensions
Gregory Smith
Solstice Advanced Materials
Performance Comparison of Fluticasone Propionate Suspension Formulations in HFO-1234ze(E) to a Reference Listed Drug
Gregory Smith
Solstice Advanced Materials
Antimicrobial Effectiveness Testing of HFO-1234ze(E) with and without Ethanol
Erik Boldt
Solstice Advanced Materials
Minimizing Variability in Shot Weight of HFO-1234ze(E) Metered Dose Inhalers Using Automated Systems Compared with Manual Handling
Erik Boldt
Solstice Advanced Materials
Adapting Standard Nasal Spray Testing Methodologies for Live BSL-2 Viral Products: An In-Use Case Study with a SARS-CoV-2 Nasal Vaccine
Yannick Baschung
Solvias
Evaluation of Metformin Encapsulated Rod-Shaped Iron (III) Carboxylate Biomimetic NanoMetal-Organic Frameworks as Antibacterial Immunotherapy
Aime Fabius Irabin
South Dakota State University
Characterization and Safety of Biomimetic Metal-Organic Frameworks in Macrophages
Joshua Reineke
South Dakota State University
Numerical and Experimental Studies to Enhance Nasopharyngeal Deposition by Optimizing Spray Plume Angle and Particulate Sizes for Intranasal Drug Delivery
Joshua Reineke
South Dakota State University
Development and Evaluation of Inhalable Imipenem Dry Powder for Treating Pulmonary Pseudomonas aeruginosa Infections
Parasharamulu Kommarajula
St. John's University
Can a Mixing Inlet Interposed Between a Pressurized Metered Dose Inhaler-Spacer Combination and Cascade Impactor Enable Effective Performance Testing at Widely Different Inhalation Flow Rates?
Mark Nagel
Trudell Medical International
Comparative Analysis of Phospholipid Porous Particle Size Distribution in Orally Inhaled Drug Products: In Vitro and In Silico Approaches
Yang Yang and Susan Boc
U.S. Food & Drug Administration
Computational Modeling of Actuation Timing Effects on Regional Lung Drug Delivery from Pressurized Metered Dose Inhalers
Bora Sul
U.S. Food & Drug Administration
Influence of Formulation Viscosity and Surface Tension on Spray Formation and Nasal Deposition with a VP7 Nasal Valve Device
Sorrel Haughton
University of Bristol
Nasal Delivery of Liquid Medicines: Effect of Viscosity and Polymer Structure on Delivery Performance
Hessam Rasooli Nia
University of Hertfordshire
Inhalable Anti-Inflammatory psLNPs Enable Mucus Penetration and circRNA CFTR Delivery For Cystic Fibrosis Therapy
You Xu and Guizhi (Julian) Zhu
University of Michigan
A Distribution-Based Metric for Quantifying Dispersibility in Dry Powder Inhalers
Grace Xia
University of Michigan
Airway Delivery of circRNA Using Pulmonary-Surfactant-Coated Lipid Nanoparticles for Cystic Fibrosis Gene Therapy
Guizhi (Julian) Zhu
University of Michigan
Direct Aerosol Administration in Preclinical Respiratory Models: Influence of the Parameters of Administration Using the Fine Mist Sprayer
Lucila Garcia-Contreras
University of Oklahoma
Development of PEGylated DNase for Nebulization
Francesca Buttini
University of Parma
Engineering Budesonide Microparticles to Improve Suspension Stability in Low-Global Warming Potential Pressurized Metered Dose Inhalers 
Francesca Buttini
University of Parma
Combination of a Newly Developed Modified Next Generation Impactor and Franz Cell Method for In Vitro Dissolution Characterization of Inhalation Powders: Development and Validation
Zhengqi Xu and Dipesh Khanal
University of Sydney
Influence of L-Leucine Content on the Internal and External Morphology of Spray-Dried Particles
Jordan Potts
Upperton Pharma Solutions
Effect of Breathing Pattern and Emitted Dose on Regional Deposition of Soft-Mist Nasal Sprays
Mohammad Hejazi
Virginia Commonwealth University
Inhalable Liposomal Combination Therapy for the Treatment of Osteosarcoma Lung Metastases
Federica Carnamucio
Virginia Commonwealth University
Investigating Effects of Single Prong Nasal Interface Orifice Diameter and Capillary-to-Orifice Distance on Air Jet Dry Power Inhaler Plume Properties and Performance
Caleb Dalton
Virginia Commonwealth University
Studying the Pharmacodynamic Response of the Tumor Immune Microenvironment in Osteosarcoma Lung Metastases Following Inhaled Gemcitabine Treatment
Victoria Garcia
Virginia Commonwealth University
Development of an Inhalation-Assisted Pediatric Dry Powder Inhaler and Synthetic Lung Surfactants Excipient Enhanced Growth Platform for Anti-Infective Aerosol Delivery
Riley Schweizer
Virginia Commonwealth University
Impact of Spray-Dryer Technology on the Aerosol Performance and Physicochemical Properties of Synthetic Dipalmitoylphosphatidylcholine Dry Powder Formulations
Baiwei Chen
Virginia Commonwealth University
Tobramycin-Synthetic Lung Surfactant Dry Powder for Treatment of Pseudomonas aeruginosa-Induced Lung Infection in Rats
Rudra Pangeni
Virginia Commonwealth University
Development and Validation of a Customizable Neonatal Breathing Simulator for Aerosol Delivery Evaluation Using a Laryngeal Mask Airway Aerosol Delivery System
Laura Vargas
Virginia Commonwealth University
Device Characteristics and Orientation Effects on Regional Nasal Drug Deposition in an Anatomical Nasal Model
Mohammad Hejazi
Virginia Commonwealth University
PEGylated Ciprofloxacin Liposomal Dry Powder: Efficacy in Acute Rat Pseudomonas aeruginosa-Induced Lung Infection
Surendra Poudel
Virginia Commonwealth University
Achieving Improved Lung Delivery of Synthetic Lung Surfactant Excipient Enhanced Growth Dry Powder Aerosol Formulations in Neonates
Mohammad Momin
Virginia Commonwealth University
Inhaler Usage Recognition Using Transformer-Based Acoustic Modeling
Ziyi Fan and Yuqing Ye
Western University
Bridging Deposition and Permeation: Evaluation of Intranasal Dry Powder Antiemetic Formulations
Patrick He
Woolcock Institute of Medical Research
Nebulization of Complex Formulations: A Physicochemical Property Tailored Strategy for Vibrating Mesh Nebulizers
Weilai Wang
Yirdoc
CONFERENCE SUPPORTERS
↑ Back to Top